NCT00502541View on ClinicalTrials.gov

Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Diabetic Macular Edema
Interventions
DRUG

fluocinolone acetonide

fluocinolone acetonide 0.59 mg intravitreal implant

PROCEDURE

Standard of Care

Repeat macular grid laser or observation

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00502541 - Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema | Biotech Hunter | Biotech Hunter